Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 183


Overexpression of N-Myc downstream-regulated gene 2 (NDRG2) regulates the proliferation and invasion of bladder cancer cells in vitro and in vivo.

Li R, Yu C, Jiang F, Gao L, Li J, Wang Y, Beckwith N, Yao L, Zhang J, Wu G.

PLoS One. 2013 Oct 16;8(10):e76689. doi: 10.1371/journal.pone.0076689. eCollection 2013.


Inhibition of N-myc downstream-regulated gene 2 in prostatic carcinoma.

Yu C, Wu G, Dang N, Zhang W, Zhang R, Yan W, Zhao Y, Gao L, Wang Y, Beckwith N, Yuan J, Yao L.

Cancer Biol Ther. 2011 Aug 15;12(4):304-13. Epub 2011 Aug 15.


Suppression of invasion and metastasis of prostate cancer cells by overexpression of NDRG2 gene.

Gao L, Wu GJ, Liu XW, Zhang R, Yu L, Zhang G, Liu F, Yu CG, Yuan JL, Wang H, Yao LB.

Cancer Lett. 2011 Nov 1;310(1):94-100. doi: 10.1016/j.canlet.2011.06.015. Epub 2011 Jun 24.


FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model.

Deuschle U, Schüler J, Schulz A, Schlüter T, Kinzel O, Abel U, Kremoser C.

PLoS One. 2012;7(10):e43044. doi: 10.1371/journal.pone.0043044. Epub 2012 Oct 9.


Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth.

Zhang H, Jiang H, Wang W, Gong J, Zhang L, Chen Z, Ding Q.

Urol Oncol. 2012 Nov-Dec;30(6):920-7. doi: 10.1016/j.urolonc.2010.10.003. Epub 2011 Apr 7.


Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer.

Lorentzen A, Lewinsky RH, Bornholdt J, Vogel LK, Mitchelmore C.

BMC Cancer. 2011 Jan 12;11:14. doi: 10.1186/1471-2407-11-14.


N-myc downstream-regulated gene 2 expression is associated with glucose transport and correlated with prognosis in breast carcinoma.

Ma J, Liu W, Guo H, Li S, Cao W, Du X, Lei S, Hou W, Xiong L, Yao L, Li N, Li Y.

Breast Cancer Res. 2014 Mar 18;16(2):R27. doi: 10.1186/bcr3628.


Short interfering RNA directed against Slug blocks tumor growth, metastasis formation, and vascular leakage in bladder cancer.

Wang X, Zhang K, Sun L, Liu J, Lu H.

Med Oncol. 2011 Dec;28 Suppl 1:S413-22. doi: 10.1007/s12032-010-9728-4. Epub 2010 Oct 30.


Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation.

Shi H, Jin H, Chu D, Wang W, Zhang J, Chen C, Xu C, Fan D, Yao L.

Biol Pharm Bull. 2009 Jun;32(6):968-75.


Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells.

Kim A, Kim MJ, Yang Y, Kim JW, Yeom YI, Lim JS.

Carcinogenesis. 2009 Jun;30(6):927-36. doi: 10.1093/carcin/bgp072. Epub 2009 Mar 31.


Suppression of MMP-9 activity by NDRG2 expression inhibits clear cell renal cell carcinoma invasion.

Ma JJ, Kong LM, Liao CG, Jiang X, Wang Y, Bao TY.

Med Oncol. 2012 Dec;29(5):3306-13. doi: 10.1007/s12032-012-0265-1. Epub 2012 Jun 13.


Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.

Slaton JW, Karashima T, Perrotte P, Inoue K, Kim SJ, Izawa J, Kedar D, McConkey DJ, Millikan R, Sweeney P, Yoshikawa C, Shuin T, Dinney CP.

Clin Cancer Res. 2001 Sep;7(9):2840-53.


Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis.

Lee DC, Kang YK, Kim WH, Jang YJ, Kim DJ, Park IY, Sohn BH, Sohn HA, Lee HG, Lim JS, Kim JW, Song EY, Kim DM, Lee MN, Oh GT, Kim SJ, Park KC, Yoo HS, Choi JY, Yeom YI.

Cancer Res. 2008 Jun 1;68(11):4210-20. doi: 10.1158/0008-5472.CAN-07-5040.


NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression.

Zheng J, Li Y, Yang J, Liu Q, Shi M, Zhang R, Shi H, Ren Q, Ma J, Guo H, Tao Y, Xue Y, Jiang N, Yao L, Liu W.

BMC Cancer. 2011 Jun 16;11:251:1-9. doi: 10.1186/1471-2407-11-251.


Expression of NDRG2 in esophageal squamous cell carcinoma.

Shi H, Li N, Li S, Chen C, Wang W, Xu C, Zhang J, Jin H, Zhang H, Zhao H, Song W, Feng Q, Feng X, Shen X, Yao L, Zhao Q.

Cancer Sci. 2010 May;101(5):1292-9. doi: 10.1111/j.1349-7006.2010.01529.x. Epub 2010 Feb 11.


Candidate of metastasis 1 regulates in vitro growth and invasion of bladder cancer cells.

Du P, Ye L, Yang Y, Jiang WG.

Int J Oncol. 2013 Apr;42(4):1249-56. doi: 10.3892/ijo.2013.1802. Epub 2013 Jan 29.


Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer.

Zhao H, Zhang J, Lu J, He X, Chen C, Li X, Gong L, Bao G, Fu Q, Chen S, Lin W, Shi H, Ma J, Liu X, Ma Q, Yao L.

BMC Cancer. 2008 Oct 22;8:303. doi: 10.1186/1471-2407-8-303.


Overexpression of immunoglobulin G prompts cell proliferation and inhibits cell apoptosis in human urothelial carcinoma.

Liang PY, Li HY, Zhou ZY, Jin YX, Wang SX, Peng XH, Ou SJ.

Tumour Biol. 2013 Jun;34(3):1783-91. doi: 10.1007/s13277-013-0717-z. Epub 2013 Mar 13.


High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.

Zhang Z, Zhang G, Kong C.

Urol Oncol. 2013 Oct;31(7):1222-30. doi: 10.1016/j.urolonc.2011.11.028. Epub 2011 Dec 20.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk